Tenax Therapeutics (TENX) Net Margin (2010 - 2015)

Tenax Therapeutics has disclosed Net Margin across 5 years of filings, most recently posting 9877.81% for Q2 2015.

• In Q2 2015, Net Margin changed N/A year-over-year to 9877.81%; the TTM figure through Jun 2016 stood at 12031.27% (up 1218728.0% YoY), while the FY2015 annual figure was 40541.31%, changed N/A from the prior year.
• Net Margin came in at 9877.81% for Q2 2015 at Tenax Therapeutics, down from 1551.5% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 10522.58% in Q1 2011 to a low of 11513.99% in Q3 2011.
• Average Net Margin over 4 years is 988.87%, with a median of 302.46% recorded in 2012.
• The largest YoY upside for Net Margin was 1283211 bps in 2012 against a maximum downside of 1538948 bps in 2012.
• Over 4 years, Net Margin stood at 3074.85% in 2011, then surged by 110 bps to 302.46% in 2012, then soared by 413 bps to 1551.5% in 2013, then tumbled by 737 bps to 9877.81% in 2015.
• Per Business Quant data, the three most recent Net Margin figures were 9877.81% in Q2 2015, 1551.5% in Q2 2013, and 1085.02% in Q1 2013.